Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons

被引:91
作者
Hartbauer, M
Hutter-Paier, B
Skofitsch, G
Windisch, M
机构
[1] Karl Franzens Univ, Dept Neurobiol, Inst Zool, A-8010 Graz, Austria
[2] Inst Expt Pharmacol Res Initiat EBEWE, Graz, Austria
[3] Karl Franzens Univ Graz, Inst Zool, Dept Histopharmacol, Graz, Austria
关键词
cerebrolysin; growth factors; apoptosis; chick neuron; neuroprotection; serum supplement;
D O I
10.1007/s007020170067
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cerebrolysin (EBEWE Arzneimittel, Austria, Europe) is a widely used drug relieving the symptoms of a variety of neurological disorders, particularly of neurodegenerative dementia of the Alzheimer's type. It consists of approximately 25% of low molecular weight peptides (<10 k DA) and a mixture of approximately 75% free amino acids, this being based on the total nitrogen content. In this study we used a low serum (2% serum supplement) cell stress in-vitro model to assess drug effectiveness on neuronal viability and programmed cell death (PCD). In this in-vitro model the type of cell death was previously shown to be primarly apoptotic, which was verified by DNA-laddering and TUNEL-staining. For evaluation of neuronal viability a MTT-reduction assay was performed after 4 DIV and 8 DIV and the percentage of apoptotic neurons was determined by bis-benzimide staining of nuclear chromatin. To differentiate between possible effects of the free amino acids and the peptide fraction of Cerebrolysin an artificial amino acid mixture (AA-mix) was used as a control. Cerebrolysin, the AA-mix and 10% foetal calf serum (FCS) caused a similar increase in viability after 4 DIV, whereas the effects of the growth factors BDNF and FGF-2 were less pronounced. After 8 DIV Cerebrolysin, but not the AA-mix, was able to ameliorate neuronal viability, which could reflect a neuro-protective effect or an increased activity of the mitochondrial dehydrogenase measured in a MTT-reduction assay. The percentage of cells showing apoptotic chromatin changes was significantly reduced (p < 0.01) in cultures treated with Cerebrolysin, whereas the AA-mix failed to decrease the percentage of cells showing apoptotic chromatin changes. These findings ascertain an anti-apoptotic effect of the peptide fraction of Cerebrolysin and reveal a transient viability promoting effect of the amino acid fraction, which is most likely due to improved nutritional supply.
引用
收藏
页码:459 / 473
页数:15
相关论文
共 48 条
[1]   The 5-HT1A receptor agonist Bay X 3702 inhibits apoptosis induced by serum deprivation in cultured neurons [J].
Ahlemeyer, B ;
Glaser, A ;
Schaper, C ;
Semkova, I ;
Krieglstein, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 370 (02) :211-216
[2]  
Ahlemeyer B, 1997, BRAIN RES, V777, P179
[3]  
AKAI F, 1992, HISTOL HISTOPATHOL, V7, P213
[4]   Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL [J].
Anderson, AJ ;
Stoltzner, S ;
Lai, F ;
Su, J ;
Nixon, RA .
NEUROBIOLOGY OF AGING, 2000, 21 (04) :511-524
[5]  
Atabay C, 1996, J NEUROSCI RES, V43, P465
[6]  
BAROLIN GS, 1996, EUROREHAB, V3, P135
[7]  
BONFOCO E, 1997, APOPTOSIS TECHNIQUES, P237
[8]   Neural apoptosis [J].
Bredesen, DE .
ANNALS OF NEUROLOGY, 1995, 38 (06) :839-851
[9]   Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease [J].
Cotman, CW .
NEUROBIOLOGY OF AGING, 1998, 19 (01) :S29-S32
[10]   Early ultrastructural changes after brief histotoxic hypoxia in cultured cortical and hippocampal CA1 neurons [J].
Dux, E ;
Oschlies, U ;
Uto, A ;
Kusumoto, M ;
Hossmann, KA .
ACTA NEUROPATHOLOGICA, 1996, 92 (06) :541-544